Skip to content
Search

Latest Stories

Covid-19 infection rate witnessed declining trend in May: study

The rate of Covid-19 infection recorded a declining trend in May, the last month of lockdown, halving every eight to nine days, a latest study has showed.

There were on average 13 positive cases for every 10,000 people, with an overall reproduction number of 0.57 – lower than previously reported, the research by Imperial College London revealed.


The findings indicate that the virus was circulating with relatively low prevalence and was declining in May, ahead of the decision to ease lockdown restrictions.

Health Secretary Matt Hancock said the findings show the impact of lockdown, besides confirming that the government has "taken the right actions at the right time."

"As a country we have made great strides towards beating this virus but we mustn’t take our foot off the pedal, and such studies will be vital as we continue to fight this virus," he added.

Over 120,000 volunteers tested across England between 1 May and 1 June, as part of the country’s largest study into coronavirus.

The report also shows anyone who had recent contact with a known Covid-19 case was 24 times more likely to test positive than those with no such contacts.

Other key findings include:

  • Young adults, aged 18 to 24, were more likely to test positive than other age groups, reinforcing the need for this age group to adhere to social distancing measures to protect vulnerable friends and family.
  • Those of Asian ethnicity were more likely to test positive than those of white ethnicity. It is possible that higher infection rates have contributed towards the higher death rates observed in this ethnic group.
  • Care home staff and healthcare workers were more likely to be infected with Covid-19 during lockdown than the general population, at a time when the public was following government advice to stay at home, therefore limiting their exposure to the virus. Those who had patient facing roles were more likely to be in contact with known cases as part of their work.

Professor Paul Elliott, director of the programme at Imperial College London, said: "Community testing is a vital step in ongoing efforts to mitigate the pandemic, but to be successful this must be based on robust scientific evidence and sound statistics.

"Through this surveillance programme with DHSC and Ipsos MORI we’re gathering the critical knowledge base necessary to underpin community testing and facilitate a greater understanding of the prevalence of Covid-19 in every corner of England."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less